LIDOPRO PATCH- lidocaine, menthol, and methyl salicylate patch

Negara: Amerika Serikat

Bahasa: Inggris

Sumber: NLM (National Library of Medicine)

Bahan aktif:

LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987), MENTHOL (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A), METHYL SALICYLATE (UNII: LAV5U5022Y) (SALICYLIC ACID - UNII:O414PZ4LPZ)

Tersedia dari:

Terrain Pharmaceuticals

INN (Nama Internasional):

LIDOCAINE HYDROCHLORIDE

Komposisi:

LIDOCAINE HYDROCHLORIDE ANHYDROUS 4 mg in 100 mg

Rute administrasi :

TOPICAL

Jenis Resep:

OTC DRUG

Indikasi Terapi:

Topical Analgesic Topical Analgesic Topical Analgesic Temporarily relieves mild to moderate aches and pains of muscles and joints associated with: • muscle soreness • strains • sprains • arthritis • simple backache • muscle stiffness • bruises • clean and dry affected area • open pouch and remove one patch containing medical adhesive backing • remove protective film from both patch and medical adhesive • apply one patch to the affected area of pain and leave in place for 8 to 12 hours • if pain lasts after using the first patch, a second patch may be applied for up to another 8 to 12 hours • only use one patch at a time • do not use more than 2 patches per day • wash hands with soap and water after applying or removing patch • reseal pouch containing unused patches after each use Children under 18 years of age: Do not use

Status otorisasi:

OTC monograph not final

Karakteristik produk

LIDOPRO PATCH- LIDOCAINE, MENTHOL, AND METHYL SALICYLATE PATCH
TERRAIN PHARMACEUTICALS
----------
LIDOPRO PATCH
METHEMOGLOBINEMIA
Cases of methemoglobinemia have been reported in association with
local anesthetic
use. Although all patients are at risk for methemoglobinemia, patients
with glucose-6-
phosphate dehydrogenase deficiency, congenital or idiopathic
methemoglobinemia,
cardiac or pulmonary compromise, infants under 6 months of age, and
concurrent
exposure to oxidizing agents or their metabolites are more susceptible
to developing
clinical manifestations of the condition. If local anesthetics must be
used in these
patients, close monitoring for symptoms and signs of methemoglobinemia
is
recommended.
Signs and symptoms of methemoglobinemia may occur immediately or may
be delayed
some hours after exposure and are characterized by a cyanotic skin
discoloration and
abnormal coloration of the blood. Methemoglobin levels may continue to
rise; therefore,
immediate treatment is required to avert more serious central nervous
system and
cardiovascular adverse effects, including seizures, coma, arrhythmias,
and death.
Discontinue lidocaine-containing products and any other oxidizing
agents. Depending on
the severity of the symptoms, patients may respond to supportive care,
i.e., oxygen
therapy, hydration. More severe symptoms may require treatment with
methylene blue,
exchange transfusion, or hyperbaric oxygen.
ACTIVE INGREDIENT
Lidocaine 4%
PURPOSE
Topical Analgesic
ACTIVE INGREDIENT
Menthol 5%
PURPOSE
Topical Analgesic
ACTIVE INGREDIENT
Methyl Salicylate 4%
PURPOSE
Topical Analgesic
USES
Temporarily relieves mild to moderate aches and pains of muscles and
joints associated
with:
• muscle soreness
• strains
• sprains
• arthritis
• simple backache
• muscle stiffness
• bruises
WARNINGS
FOR EXTERNAL USE ONLY
STOMACH BLEEDING WARNING
This product contains an NSAID, which may cause stomach bleeding. The
chance is
small, but higher if you
• are age 60 or older
• have had stomach ulcers or bleeding proble